MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-05-2026
National Research Corporation EV - Enterprise Value 2011-2026 | NRC
Annual EV - Enterprise Value National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 432 M | 431 M | 1.08 B | 1.17 B | 1.08 B | 1.17 B | 1.78 B | 1.14 B | 901 M | 421 M | 378 M | 337 M | 391 M | 35 M | 37 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.78 B | 35 M | 718 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
45.8 B | $ 118.37 | -1.17 % | $ 36 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 19.58 | -4.79 % | $ 211 M |  China |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 520.39 | 0.36 % | $ 15 B | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 21.48 | 22.25 % | $ 1.14 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
NeoGenomics
NEO
|
1.85 B | $ 8.39 | -3.34 % | $ 1.07 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 29.06 | -0.1 % | $ 20 B |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 1.41 | -0.69 % | $ 1.88 M | USA |
 |
Castle Biosciences
CSTL
|
665 M | $ 24.39 | -0.93 % | $ 677 M | USA |
 |
Senseonics Holdings
SENS
|
376 M | $ 6.77 | -1.88 % | $ 282 M | USA |
 |
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.62 | 0.09 % | $ 2.67 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Neuronetics
STIM
|
168 M | $ 1.35 | -2.87 % | $ 89 M | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 181.2 | 0.35 % | $ 8.98 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 524.15 | -1.41 % | $ 198 B | USA |
 |
Danaher Corporation
DHR
|
145 B | $ 194.8 | -1.69 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 1.95 | -11.36 % | $ 8.63 M | USA |
 |
Trinity Biotech plc
TRIB
|
133 M | $ 0.7 | -0.83 % | $ 61.9 M |  Irlanda |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 56.37 | -2.17 % | $ 3.37 B | USA |
 |
Illumina
ILMN
|
15.3 B | $ 130.3 | -1.48 % | $ 20.7 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 15.95 | -1.36 % | $ 482 M | USA |
 |
Guardant Health
GH
|
15.2 B | $ 84.69 | -0.21 % | $ 10.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
990 K | $ 2.82 | -3.75 % | $ 91.5 K | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.19 | 3.79 % | $ 5.03 M | USA |
 |
Waters Corporation
WAT
|
21.6 B | $ 321.93 | -1.31 % | $ 19.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 116.76 | 0.22 % | $ 9.63 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 268.36 | 0.61 % | $ 22.3 B | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
5.57 B | $ 123.75 | 0.23 % | $ 5.79 B | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 5.16 | -0.67 % | $ 478 M | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 83.68 | -0.31 % | $ 5.65 B | USA |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.26 | -1.7 % | $ 2.01 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 193.65 | 1.16 % | $ 21.5 B | USA |